title: SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E.
abstract: SNF5, a core component of the SWI/SNF chromatin remodeling complex, is expressed as two isoforms, SNF5a and SNF5b. SNF5 is a tumor suppressor, as mutation of SNF5 leads to tumor formation and cooperates with p53 deficiency to enhance cancer susceptibility. Interestingly, lack of SNF5 inhibits cell survival and embryonic development, potentially through abnormal activation of p53. To further examine this, we generated cell lines in which SNF5a, SNF5b or both can be inducibly knocked down. We found that SNF5 knockdown leads to cell-cycle arrest in G(1), and SNF5a and SNF5b are functionally redundant. We also showed that SNF5 knockdown impairs p53-dependent transcription of p21 and murine double minute 2. However, contrary to earlier reports that p53 is activated by SNF5 knockout in murine cells, SNF5 knockdown leads to decreased, but not increased, expression of both basal and stress-induced p53 in multiple human cell lines. In addition, we showed that SNF5 knockdown induces adenosine monophosphate-activated protein kinase activation and inhibits eIF4E expression. Finally, we showed that SNF5 knockdown inhibits p53 translation by eIF4E and replacement of eIF4E in SNF5 knockdown cells restores p53 expression and cell survival. Together, our study results suggest that the p53 pathway is regulated by, and mediates the activity of, SNF5 in tumor suppression and prosurvival.
authors.affiliation: Center for Comparative Oncology, University of California, Davis, CA 95616, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Xu
authors.forename: W
authors.initials: W
authors.lastname: Yan
authors.forename: X
authors.initials: X
authors.lastname: Chen
mesh_terms: D000263:Adenylate Kinase / Q000378:metabolism; D000818:Animals; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000502:physiology*; D002868:Chromosomal Proteins, Non-Histone / Q000235:genetics / Q000502:physiology*; D039561:Eukaryotic Initiation Factor-4E / Q000502:physiology*; D055785:Gene Knockdown Techniques; D006801:Humans; D051379:Mice; D010766:Phosphorylation; D034741:RNA, Small Interfering; D000071796:SMARCB1 Protein; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D002868:Chromosomal Proteins, Non-Histone; D039561:Eukaryotic Initiation Factor-4E; D034741:RNA, Small Interfering; D000071796:SMARCB1 Protein; C513265:Smarcb1 protein, mouse; D016159:Tumor Suppressor Protein p53; D000263:Adenylate Kinase
references.citation: Cancer Cell. 2002 Nov;2(5):415-25
references.pmid: 12450796
references.citation: Mol Cell Biol. 2001 May;21(10):3598-603
references.pmid: 11313485
references.citation: Histol Histopathol. 2008 Sep;23(9):1143-9
references.pmid: 18581285
references.citation: Curr Opin Genet Dev. 1996 Apr;6(2):171-5
references.pmid: 8722173
references.citation: Am J Hum Genet. 1999 Nov;65(5):1342-8
references.pmid: 10521299
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13796-800
references.pmid: 11095756
references.citation: Cell. 2005 Oct 7;123(1):49-63
references.pmid: 16213212
references.citation: EMBO Rep. 2000 Dec;1(6):500-6
references.pmid: 11263494
references.citation: Mol Cell Biol. 2008 Oct;28(20):6223-33
references.pmid: 18710953
references.citation: Hum Mol Genet. 1999 Dec;8(13):2359-68
references.pmid: 10556283
references.citation: Mol Cell Biol. 2005 Mar;25(5):2014-30
references.pmid: 15713654
references.citation: Mol Cell. 2008 Apr 25;30(2):214-26
references.pmid: 18439900
references.citation: Mol Cell Biol. 1984 Sep;4(9):1689-94
references.pmid: 6092932
references.citation: Genes Dev. 2001 Mar 1;15(5):603-18
references.pmid: 11238380
references.citation: Nucleic Acids Res. 2009 Aug;37(15):4965-76
references.pmid: 19528079
references.citation: EMBO J. 2005 Sep 21;24(18):3313-24
references.pmid: 16138077
references.citation: Genes Dev. 2005 Mar 15;19(6):665-70
references.pmid: 15769941
references.citation: Cancer Res. 2008 Feb 1;68(3):631-4
references.pmid: 18245460
references.citation: Cell Mol Life Sci. 2004 Apr;61(7-8):822-42
references.pmid: 15095006
references.citation: Nat Rev Cancer. 2009 Oct;9(10):701-13
references.pmid: 19693097
references.citation: Mol Cell Biol. 2006 Apr;26(7):2661-74
references.pmid: 16537910
references.citation: Nat Rev Cancer. 2004 Feb;4(2):133-42
references.pmid: 14964309
references.citation: Nature. 1998 Jul 9;394(6689):203-6
references.pmid: 9671307
references.citation: J Biol Chem. 2004 Feb 6;279(6):4180-5
references.pmid: 14630919
references.citation: Curr Opin Genet Dev. 2003 Apr;13(2):136-42
references.pmid: 12672490
references.citation: Cell. 1998 Nov 25;95(5):717-28
references.pmid: 9845373
references.citation: Curr Opin Cell Biol. 1994 Jun;6(3):396-402
references.pmid: 7917331
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3364-9
references.pmid: 10725359
references.citation: Oncogene. 2008 Mar 27;27(14):2035-44
references.pmid: 17922027
references.citation: Cell. 2003 Nov 26;115(5):577-90
references.pmid: 14651849
references.citation: Genes Dev. 2003 Aug 1;17(15):1829-34
references.pmid: 12869586
references.citation: J Biol Chem. 2007 Dec 28;282(52):37429-35
references.pmid: 17938176
references.citation: Genes Dev. 1996 May 1;10(9):1054-72
references.pmid: 8654922
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17745-50
references.pmid: 16301525
references.citation: Cancer Res. 2007 Apr 1;67(7):3002-9
references.pmid: 17409406
references.citation: Mol Cell Biol. 2006 Feb;26(4):1398-413
references.pmid: 16449651
references.citation: Cancer Res. 1995 Oct 1;55(19):4257-63
references.pmid: 7671232
references.citation: J Biol Chem. 2002 Jun 21;277(25):22330-7
references.pmid: 11950834
references.citation: Genes Dev. 1999 Sep 15;13(18):2339-52
references.pmid: 10500090
references.citation: J Biol Chem. 2004 Jan 30;279(5):3807-16
references.pmid: 14604992
references.citation: Mol Cell Biol. 2002 Aug;22(16):5975-88
references.pmid: 12138206